Metalloproteinases mediate diabetes-induced retinal neuropathy and vasculopathy

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections

(2018) Rupert R A Bourne et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Immunomodulation as Rescue for Chronic Atonic Skin Wounds

(2018) Ghislain Opdenakker et al.   TRENDS IN IMMUNOLOGY

Repeatability of ARK-30 in a pediatric population

(2018) Raul Martin et al.   INDIAN JOURNAL OF OPHTHALMOLOGY

Chemokine isoforms and processing in inflammation and immunity

(2017) Paul Proost et al.   JOURNAL OF AUTOIMMUNITY

Pharmacologic management of diabetic retinopathy

(2017) Akiyoshi Uemura   JOURNAL OF BIOCHEMISTRY

Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation

(2017) Robert H. Scannevin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of functional SNP-1562C > T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients

(2017) Kanhaiya Singh et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Novel therapeutic targets in diabetic macular edema: Beyond VEGF

(2017) Elizabeth A. Urias et al.   VISION RESEARCH

Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy

(2016) Ahmed M. Abu El-Asrar et al.   ACTA OPHTHALMOLOGICA

Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy

(2016) Ahmed M. Abu El-Asrar et al.   CURRENT EYE RESEARCH

Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy

(2016) Renu A Kowluru et al.   LABORATORY INVESTIGATION

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients

(2016) Jin-woo Kwon et al.   PLoS One

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology

(2016) Olga Simó-Servat et al.   Journal of Diabetes Research

Basigin can be a therapeutic target to restore the retinal vascular barrier function in the mouse model of diabetic retinopathy

(2016) Mitsuru Arima et al.   Scientific Reports

Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1

(2015) Jennifer Vandooren et al.   BIOCHEMICAL JOURNAL

Unconventional techniques of fundus imaging: A review

(2015) MaheshP Shanmugam et al.   INDIAN JOURNAL OF OPHTHALMOLOGY

EMMPRIN, an upstream regulator of MMPs, in CNS biology

(2015) Deepak Kumar Kaushik et al.   MATRIX BIOLOGY

Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence

(2015) Rafael Simó et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodies

(2015) Lies De Groef et al.   BMC Ophthalmology

ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function

(2015) Dan Cui et al.   Scientific Reports

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

(2015) Derek C. Marshall et al.   PLoS One

Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema

(2014) Marcus A. Bearse et al.   Current Diabetes Reports

Characterization of Oxygen-Induced Retinopathy in Mice Carrying an Inactivating Point Mutation in the Catalytic Site of ADAM15

(2014) T. Maretzky et al.   INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Retinal Imaging in the Twenty-First Century

(2014) Pearse A. Keane et al.   OPHTHALMOLOGY

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy

(2014) Ahmed M. Abu El-Asrar et al.   PLoS One

Functional links between gelatinase B/matrix metalloproteinase-9 and prominin-1/CD133 in diabetic retinal vasculopathy and neuropathy

(2014) Ghulam Mohammad et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Effect of Doxycycline vs Placebo on Retinal Function and Diabetic Retinopathy Progression in Mild to Moderate Nonproliferative Diabetic Retinopathy

(2014) Ingrid U. Scott et al.   JAMA Ophthalmology

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade

(2013) Jennifer Vandooren et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Matrix Metalloproteinase 14 in the Zebrafish: An Eye on Retinal and Retinotectal Development

(2013) Els Janssens et al.   PLoS One

Unlocking the biology of RAGE in diabetic microvascular complications

(2013) Michaele B. Manigrasso et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Missing the target: matrix metalloproteinase antitargets in inflammation and cancer

(2013) Antoine Dufour et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Betacellulin Induces Increased Retinal Vascular Permeability in Mice

(2010) Bela Anand-Apte et al.   PLoS One

ADAM9 Is Involved in Pathological Retinal Neovascularization

(2009) V. Guaiquil et al.   MOLECULAR AND CELLULAR BIOLOGY

Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis

(2008) Jessica S. Blackburn et al.   AMERICAN JOURNAL OF PATHOLOGY

Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictions

(2008) F. J. Descamps et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead

(2007) V. W.M. van Hinsbergh et al.   CARDIOVASCULAR RESEARCH